About Us

About Us

PSI is a global member organisation dedicated to leading and promoting best practice and industry initiatives for statisticians.

Founded in 1977 for pharmaceutical statisticians, members now span statisticians and statistical programmers working in all areas of drug development and healthcare, including research, pre-clinical, production, quality control, health technology, marketing, market research, academic statisticians and consultants.

As a non-profit organisation run by and for members, PSI delivers unrivaled support to its members throughout their careers, from education through to retirement. It continues to grow and evolve in order to lead and promote statistical thinking within all areas of the industry.

PSI delivers timely and relevant opportunities, support and resources including online training, networking events, specialist groups and committees, plus the renowned journal and annual conference.  Its aim is to inspire statisticians in healthcare to connect, learn and advance – so that all members are best placed to continue to serve the needs of this ever-changing and stimulating industry.

Together with other European statistical organisations, PSI is a member of the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI). In this capacity, PSI monitors and responds to appropriate regulatory statistical issues within the pharmaceutical industry.

There are approximately 1000 members and eight honorary life-members of PSI. Members of PSI are statisticians and statistical programmers working in all areas of the drug development process.The activities of PSI are largely planned, organised and implemented by the various committees and subgroups, under the direction of the Board of Directors.

PSI Board of Directors
 

Fiona Brock

Treasurer

Rebecca Sudlow 

External Affairs & EFSPI

Nigel Howitt

Secretary and Membership

Anna Berglind

Regulatory Chair

Naomi Givens

Partnership Director

Ray Harris

Publications Chair

Gemma Hodgson

Training Committee Chair

Nigel Howitt

Commercial Director

Tim Rolfe

SIGs Chair

Lucy Rowell

Conference Chair

Mouna Akacha

Scientific Chair

Vicky Marriott

CALC 

Craig McIlloney

Statistical Computing and Website Director

Mark Morris

Chair

To see the PSI Committee Structure please click here

 PSI activities include:

An annual three day conference which provides a forum for discussion of the application of statistics, key new developments and other hot topics impacting on the work of statisticians and statistical programmers in the industry. 

A number of one-day scientific meetings and webinars (at times as joint meetings with other professional bodies). The topics of these meetings include statistical techniques, applications in pre-clinical and clinical trials, therapeutic areas, as well as regulatory and management issues.

A variety of training courses, including the notable "Introduction to Industry" training course (ITIT), for statisticians new to the industry. This course aims to broaden the participants' knowledge and appreciation of the drug development process from discovery through to marketing. 

A quarterly newsletter (SPIN). 

A bi-weekly newsletter PSI eNews

Access to the members-only area of this website, including online discussion forums, event booking, a Resource Centre and the membership database.

Please click here to apply to join PSI


Latest News


Show all news

EventsFuture Events


  • Expert Working Group on Confidentiality of Interim Results - Dates: 11 May, 2017

    The PSI/EFSPI expert working group on Confidentiality of Interim Results are planning to meet face to face on 11 May.
  • Estimating Sample Sizes in Clinical Trials - Dates: 28 – 29 Jun, 2017

    The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design. The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
Leeds-80x250

Medical Statistician / Senior Medical Statistician

read more...

GSK logo

Director, Statistics

read more...

Astrazeneca

Associate Director, Statistics Team leader - Early Clinical Development

read more...

Astrazeneca

Early Clinical Development – various levels

read more...

LOGO

Biostatistics Head of Department

read more...

Astrazeneca

Principal Statistician – Centralised Statistical Monitoring

read more...

Astrazeneca

Clinical Trial Design Methodology Expert - Statistical Innovation Team

read more...